Show simple item record

dc.contributor.authorHotaling, Nathan A.
dc.contributor.authorBabensee, Julia E.
dc.contributor.authorTang, Li
dc.contributor.authorIrvine, Darrell J
dc.date.accessioned2017-04-13T18:35:10Z
dc.date.available2017-04-13T18:35:10Z
dc.date.issued2015-12
dc.date.submitted2015-09
dc.identifier.issn1523-9829
dc.identifier.issn1545-4274
dc.identifier.urihttp://hdl.handle.net/1721.1/108131
dc.description.abstractStrategies to enhance, suppress, or qualitatively shape the immune response are of importance for diverse biomedical applications, such as the development of new vaccines, treatments for autoimmune diseases and allergies, strategies for regenerative medicine, and immunotherapies for cancer. However, the intricate cellular and molecular signals regulating the immune system are major hurdles to predictably manipulating the immune response and developing safe and effective therapies. To meet this challenge, biomaterials are being developed that control how, where, and when immune cells are stimulated in vivo, and that can finely control their differentiation in vitro. We review recent advances in the field of biomaterials for immunomodulation, focusing particularly on designing biomaterials to provide controlled immunostimulation, targeting drugs and vaccines to lymphoid organs, and serving as scaffolds to organize immune cells and emulate lymphoid tissues. These ongoing efforts highlight the many ways in which biomaterials can be brought to bear to engineer the immune system.en_US
dc.description.sponsorshipBill & Melinda Gates Foundationen_US
dc.description.sponsorshipUnited States. Army Research Office. Institute for Soldier Nanotechnologies (Contract W911NF-13-D-0001)en_US
dc.description.sponsorshipRagon Institute of MGH, MIT and Harvarden_US
dc.description.sponsorshipCancer Research Institute (New York, N.Y.) (Irvington Postdoctoral Fellowship)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Awards AI104715, CA172164, CA174795, and AI095109)en_US
dc.language.isoen_US
dc.publisherAnnual Reviewsen_US
dc.relation.isversionofhttp://dx.doi.org/10.1146/annurev-bioeng-071813-104814en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePMCen_US
dc.titleBiomaterial Strategies for Immunomodulationen_US
dc.typeArticleen_US
dc.identifier.citationHotaling, Nathan A., Li Tang, Darrell J. Irvine, and Julia E. Babensee. “Biomaterial Strategies for Immunomodulation.” Annual Review of Biomedical Engineering 17, no. 1 (December 7, 2015): 317–349.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Mechanical Engineeringen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorTang, Li
dc.contributor.mitauthorIrvine, Darrell J
dc.relation.journalAnnual Review of Biomedical Engineeringen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsHotaling, Nathan A.; Tang, Li; Irvine, Darrell J.; Babensee, Julia E.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-4244-5978
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record